Legalize59765 laws
59765 laws
- § 360g–2. Third party data transparency
- § 360h. Notification and other remedies
- § 360hh. Definitions
- § 360h–1. Program to improve the device recall system
- § 360i. Records and reports on devices
- § 364h. Small businesses
- § 360ii. Program of control
- § 360j. General provisions respecting control of devices intended for human use
- § 360jj. Studies by Secretary
- § 360k. State and local requirements respecting devices
- § 360kk. Performance standards for electronic products
- § 360l. Postmarket surveillance
- § 360ll. Notification of defects in and repair or replacement of electronic products
- § 360m. Accredited persons
- § 364i. Exemption for certain products and facilities
- § 360mm. Imports
- § 360n. Priority review to encourage treatments for tropical diseases
- § 360nn. Inspection, records, and reports
- § 360n–1. Priority review for qualified infectious disease products
- § 360n–2. Ensuring cybersecurity of devices
- § 360oo. Prohibited acts
- § 360pp. Enforcement
- § 360qq. Repealed. [Pub. L. 105–362, title VI, § 601(a)(2)(A)](/us/pl/105/362/tVI/s601/a/2/A), Nov. 10, 1998, [112 Stat. 3285](/us/stat/112/3285)
- § 360rr. Federal-State cooperation
- § 360ss. State standards
- § 361. Adulterated cosmetics
- § 362. Misbranded cosmetics
- § 363. Regulations making exemptions
- § 364. Definitions
- § 364a. Adverse events
- § 364b. Good manufacturing practice
- § 364c. Registration and product listing
- § 364d. Safety substantiation
- § 364e. Labeling
- § 364f. Records
- § 364g. Mandatory recall authority
- § 378. Advertising of foods
- § 379. Confidential information
- § 379a. Presumption of existence of jurisdiction
- § 379aa. Serious adverse event reporting for nonprescription drugs
- § 379aa–1. Serious adverse event reporting for dietary supplements
- § 379b. Consolidated administrative and laboratory facility
- § 379c. Transferred
- § 379d. Automation of Food and Drug Administration
- § 379dd. Establishment and functions of the Foundation
- § 379dd–1. Location of Foundation
- § 379dd–2. Activities of the Food and Drug Administration
- §§ 97 to 97d. Omitted
- § 379d–1. Conflicts of interest
- § 379d–2. Policy on the review and clearance of scientific articles published by FDA employees